Nitinotes Announces Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center Clinical Site Activation in the EASE™ IDE Trial

Trial StartEndoZip™ Automated Suturing SystemPositive

AI Analysis

Summary

Nitinotes announced the activation of Weill Cornell Medicine as a clinical site in the EASE™ IDE trial for its EndoZip™ Automated Suturing System, with the first patient treated by Dr. Reem Sharaiha.

Clinical Trial Data

Outcome Details

First study patient treated at Weill Cornell Medicine clinical site

Importance:4/10

Sentiment:

0.60

Clinical trialMedical deviceEndoscopyBariatric surgeryIDE trial

Related Companies

$SHWZ $MDCE $TRAX

Read the original article

Published by PR Newswire Biotech on August 11, 2026 1:30 PM

Read Original